Related Experiment Video
Updated: Jan 15, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Reducing medication errors in neurosurgery through clinical pharmacy interventions: a prospective observational
Aaron Lawson McLean1, Anna Schlattl2,3,4, Christian Senft5
1Department of Neurosurgery, Jena University Hospital, Friedrich Schiller University Jena, Am Klinikum 1, 07747, Jena, Germany. aaron.lawsonmclean@med.uni-jena.de.
A pharmacist-led medication review program in neurosurgery reduced medication errors and improved patient outcomes. This initiative led to shorter hospital stays and lower mortality rates, highlighting the value of clinical pharmacists in complex care settings.
Area of Science:
- Neurosurgery
- Clinical Pharmacy
- Patient Safety
Background:
- Neurosurgical care is complex, with high rates of polypharmacy, elderly patients, and comorbidities, increasing medication error risks.
- Dynamic treatment plans and intensive care needs further complicate medication management in neurosurgery.
Purpose of the Study:
- To evaluate the impact of a structured, weekly pharmacist-led medication review program on prescribing practices and patient outcomes in a neurosurgical department.
- To assess the effectiveness of pharmacist interventions in enhancing medication safety and improving clinical results within this high-risk patient population.
Main Methods:
- A 12-month prospective study involving weekly medication reviews by a clinical pharmacist on a neurosurgical ward and high-dependency unit (HDU).
- Interventions were documented, with 10% re-audited for uptake. Data from the intervention year were compared to historical controls for length of stay (LOS) and in-hospital mortality.
- The study period was divided into two six-month epochs to analyze temporal trends in intervention rates.
Main Results:
- A total of 996 interventions were documented for 1795 patients (0.55 interventions/patient).
- Median LOS decreased from 8.1 to 7.3 days (p=0.032), prolonged hospitalizations (>14 days) fell from 18.9% to 14.8% (p=0.002), and in-hospital mortality declined from 4.6% to 3.0% (p=0.014).
- Intervention rates showed a learning effect, declining from 0.7 to 0.4 per patient between epochs (p=0.016), with 78% implementation of recommendations.
Conclusions:
- Routine integration of clinical pharmacists into neurosurgical care significantly reduces medication-related issues.
- The program demonstrated measurable improvements in LOS and mortality, supporting pharmacist-led interventions in high-risk surgical environments.
- Further controlled multicenter trials are warranted to validate these findings and support broader implementation.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Dosing: Geriatric Patients
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Drug Therapy
Antianxiety Medications
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security:

